Qianyuan Pharmaceuticals: Shareholder Weng Zhanguo has reduced his holdings by 2.54%

2026-03-02 06:53:27

Qianyuan Pharmaceuticals announces that shareholder Weng Zhanguo’s reduction plan has been completed as of February 12, 2026. During the period, he reduced 1.5353 million shares through centralized bidding from November 13 to November 26, 2025, accounting for 0.60% of the total share capital, at an average price of 10.98 yuan per share; and reduced 4.9671 million shares through block trades from November 19 to November 25, accounting for 1.94%, at an average price of 8.5 yuan per share. In total, he reduced 6.5024 million shares, representing 2.54%. After the reduction, his shareholding decreased to 9.27 million shares, or 3.62%, and the reduction plan has been fully implemented.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes